PubRank

Daniel R Altmann

Author PubWeight™ 46.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007 3.47
2 Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005 3.45
3 Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004 3.23
4 Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 2012 3.15
5 Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2006 2.35
6 An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2007 2.18
7 Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol 2010 2.03
8 Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008 1.91
9 Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology 2009 1.66
10 Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging 2007 1.54
11 A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 2010 1.48
12 A serial MRI study following optic nerve mean area in acute optic neuritis. Brain 2004 1.32
13 Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. Neuroimage 2006 1.20
14 White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. Neuroimage 2007 1.18
15 The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. Trials 2011 1.09
16 Adaptive cortical plasticity in higher visual areas after acute optic neuritis. Ann Neurol 2005 1.05
17 Early factors associated with axonal loss after optic neuritis. Ann Neurol 2011 1.02
18 Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study. J Neurol 2004 0.99
19 Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. Arch Neurol 2008 0.96
20 Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis. Mult Scler 2010 0.94
21 Improved MRI quantification of spinal cord atrophy in multiple sclerosis. J Magn Reson Imaging 2013 0.93
22 Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis. Biol Psychiatry 2010 0.92
23 Principal component and linear discriminant analysis of T1 histograms of white and grey matter in multiple sclerosis. Magn Reson Imaging 2006 0.90
24 A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis. J Neurol 2007 0.88
25 Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. Mult Scler 2004 0.83
26 Scanning laser polarimetry quantification of retinal nerve fiber layer thinning following optic neuritis. J Neuroophthalmol 2010 0.82
27 Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI. Hum Brain Mapp 2012 0.80
28 TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis. Mult Scler 2010 0.79
29 Quantitative analysis of whole-tumor Gd enhancement histograms predicts malignant transformation in low-grade gliomas. J Magn Reson Imaging 2007 0.76
30 Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a. J Negat Results Biomed 2004 0.75
31 ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI. Mult Scler 2012 0.75